SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3524MGI PHARMA Files Shelf Registration Statement Tuesday June 17, 7:03 am ET MINNEsim16/17/2003
3523Are these companies expected to pay back the principal on these bonds--or do theMike McFarland6/17/2003
3522>> Icos terms << Who would have thought, given 2001-2002, that invescaram(o)uche6/17/2003
3521Not really. I can add a few ramblings to what you and Peter say, but they'rtuck6/17/2003
3520Do you have much feel for how much convertible bond buyers typically short the sDoc Bones6/17/2003
3519Icos terms. Those terms look very good for Icos. The money is almost free. It iIcebrg6/16/2003
3518Amylin Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Mondscaram(o)uche6/16/2003
3517priced...... ICOS Prices Private Offering of 2.0% Convertible Subordinated Notescaram(o)uche6/16/2003
3516ICOS Announces Proposed Private Offering of Convertible Subordinated Notes MondaIcebrg6/16/2003
3515Dendreon Corp Raises $26.7 M DOW JONES NEWSWIRES SEATTLE -- Dendreon Corp. (DNmopgcw6/16/2003
3514That's nice, but I hope the $600k didn't come out of its stem cell budgekeokalani'nui6/15/2003
3513Novo Nordisk Pharmaceuticals, Inc. Provides Grant to Support Diabetes Research Sscaram(o)uche6/15/2003
3512SOUTH SAN FRANCISCO, Calif., June 12 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nnigel bates6/13/2003
3511>> Don't like the issue of convertible debt by companies that are not scaram(o)uche6/12/2003
3510Biotech firms eye rally hungrily By Naomi Aoki, Globe Staff, 6/12/2003 precipiIcebrg6/12/2003
3509A lot of small financings going on (along with the bigger stuff like CRXA and GLnigel bates6/12/2003
3508Biotech Corixa's reserves swell with $130 million cash infusion By Tricia Micawber6/12/2003
3507Martek's DHA Granted European Novel Food Status Tuesday June 10, 4:42 pm ET scaram(o)uche6/10/2003
3506The Michael J. Fox Foundation Awards Over $2 Million to Study the Role of Inflamscaram(o)uche6/10/2003
3505>> Now that's being upfront about it. Wow. << Good to see. Parscaram(o)uche6/10/2003
3504>>BALTIMORE, June 10 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Intuck6/10/2003
3503>>ANN ARBOR, Mich. and BASKING RIDGE, N.J., June 10 /PRNewswire/ -- QuatRxtuck6/10/2003
3502Wow. Nice. Recent regulatory and clinical events, and there's a gold rush.scaram(o)uche6/6/2003
3501Cephalon Prices $600 Million Convertible Subordinated Notes Offering Friday JuneIcebrg6/6/2003
3500Yes Peter, you are correct as always: From the PR <i>The interest rate, Icebrg6/5/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News